K Braham

687 total citations
8 papers, 590 citations indexed

About

K Braham is a scholar working on Oncology, Immunology and Neurology. According to data from OpenAlex, K Braham has authored 8 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Immunology and 3 papers in Neurology. Recurrent topics in K Braham's work include Viral-associated cancers and disorders (3 papers), Neuroblastoma Research and Treatments (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). K Braham is often cited by papers focused on Viral-associated cancers and disorders (3 papers), Neuroblastoma Research and Treatments (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). K Braham collaborates with scholars based in France and United States. K Braham's co-authors include Thomas Tursz, Marta M. Lipinski, Jean‐Michel Caillaud, Marc Lipinski, Pierre Busson, Hiro Wakasugi, G. Ganem, C Carlu, Bernard Clausse and Francine Mugneret and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and International Journal of Cancer.

In The Last Decade

K Braham

8 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Braham France 7 282 178 146 120 99 8 590
R. Handgretinger Germany 15 222 0.8× 228 1.3× 226 1.5× 32 0.3× 286 2.9× 33 718
P. Caverivière France 13 359 1.3× 120 0.7× 205 1.4× 79 0.7× 86 0.9× 30 865
Rachel Koldej Australia 17 247 0.9× 293 1.6× 162 1.1× 83 0.7× 49 0.5× 59 771
KS Zuckerman United States 14 127 0.5× 295 1.7× 271 1.9× 89 0.7× 64 0.6× 27 1.0k
Kentaro Fujii Japan 15 141 0.5× 269 1.5× 293 2.0× 91 0.8× 97 1.0× 60 808
Marie‐Laure Boulland France 12 306 1.1× 117 0.7× 398 2.7× 61 0.5× 100 1.0× 20 866
Yuji Nakata United States 12 106 0.4× 332 1.9× 119 0.8× 52 0.4× 26 0.3× 27 707
Ashley Plant United States 11 166 0.6× 130 0.7× 193 1.3× 69 0.6× 125 1.3× 29 550
Jessica Van Ziffle United States 14 229 0.8× 194 1.1× 109 0.7× 167 1.4× 59 0.6× 41 746
Daniel C. Zedek United States 16 274 1.0× 259 1.5× 130 0.9× 61 0.5× 46 0.5× 41 762

Countries citing papers authored by K Braham

Since Specialization
Citations

This map shows the geographic impact of K Braham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Braham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Braham more than expected).

Fields of papers citing papers by K Braham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Braham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Braham. The network helps show where K Braham may publish in the future.

Co-authorship network of co-authors of K Braham

This figure shows the co-authorship network connecting the top 25 collaborators of K Braham. A scholar is included among the top collaborators of K Braham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Braham. K Braham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Busson, Pierre, G. Ganem, Francine Mugneret, et al.. (1988). Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas. International Journal of Cancer. 42(4). 599–606. 189 indexed citations
2.
Busson, Pierre, K Braham, Bernard Clausse, & Thomas Tursz. (1988). Constitutive expression of HLA class II antigens on EBV positive malignant cells from nasopharyngeal carcinoma: possible involvement in T cell infiltration.. PubMed. 12(1-6). 363–8. 6 indexed citations
3.
Braham, K, et al.. (1988). Kinetic analysis of choriocarcinoma cell intoxication induced by ricin and ricin A chain immunotoxin.. PubMed. 48(4). 806–11. 10 indexed citations
4.
Lipinski, Marc, K Braham, Irène Philip, et al.. (1987). Neuroectoderm-associated antigens on Ewing's sarcoma cell lines.. PubMed. 47(1). 183–7. 114 indexed citations
5.
Busson, Pierre, K Braham, G. Ganem, et al.. (1987). Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha.. Proceedings of the National Academy of Sciences. 84(17). 6262–6266. 60 indexed citations
6.
Lipinski, Marc, K Braham, Irène Philip, et al.. (1986). Phenotypic characterization of Ewing sarcoma cell lines with monoclonal antibodies. Journal of Cellular Biochemistry. 31(4). 289–296. 20 indexed citations
7.
Caillaud, Jean‐Michel, et al.. (1984). HNK-1-defined antigen detected in paraffin-embedded neuroectoderm tumors and those derived from cells of the amine precursor uptake and decarboxylation system.. PubMed. 44(10). 4432–9. 72 indexed citations
8.
Lipinski, Marta M., K Braham, Jean‐Michel Caillaud, C Carlu, & Thomas Tursz. (1983). HNK-1 antibody detects an antigen expressed on neuroectodermal cells.. The Journal of Experimental Medicine. 158(5). 1775–1780. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026